BEIGENE, LTD.

Company

BeOne Medicines Ltd.

Filed

February 18, 2016

Accession Number

0000902664-16-005959

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →